1.
|
Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: FRAG-A001-401, NCT00942968
|
|
2.
|
Phase: Phase IV
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0487, NCT00966277
|
|
3.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-979251, NCI-P98-0139, NCT00003674
|
|
4.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068075, P30CA016042, UCLA-9910055, P-UPJOHN-98-FRAG-076, NCI-G00-1822, NCT00006083
|
|
5.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: URCC-U2200, NCI-5012, NCI-CCC-99-45, NCI-P02-0212, URCC 5012, NCT00031837
|
|
6.
|
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 524E-CVD-0056-013, NCT00135876
|
|
7.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 75
Sponsor: Other
Protocol IDs: NRA6300011-FOCUS-II, NCT00239980
|
|
8.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000069119, E1F01, ECOG-E1F01, NCT00028678
|
|
9.
|
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 30 and over
Sponsor: Other
Protocol IDs: 2004-0743, NCT00525057
|
Mobile | Español
